Galapagos NV (GLPG)
29.42
-0.34
(-1.14%)
USD |
NASDAQ |
Apr 02, 16:00
29.50
+0.08
(+0.27%)
After-Hours: 20:00
Galapagos Free Cash Flow : -238.89M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Gilead Sciences, Inc. | 9.456B |
| UCB SA | 1.999B |
| Celyad Oncology SA | -8.047M |
| Fagron NV | 113.90M |
| AgomAb Therapeutics NV | -- |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -48.96M |
| Cash from Investing (Quarterly) | 77.51M |
| Cash from Financing (Quarterly) | -0.4763M |
| Free Cash Flow Per Share (Quarterly) | -0.7717 |
| Free Cash Flow to Equity (Quarterly) | -50.16M |
| Free Cash Flow to Firm (Quarterly) | -49.88M |
| Free Cash Flow Yield | -12.32% |